![Karl Keegan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Keegan
Directeur/Membre du Conseil chez
Novai Ltd.
Profil
Karl David Keegan is currently a Non-Executive Director at Novai Ltd. and a Life Science Analyst at Singer Capital Markets Securities Ltd. since 2022.
Former roles include Chief Executive Officer & Director at Hox Therapeutics Ltd., Independent Non-Executive Director at Conroy Gold & Natural Resources Plc from 2017 to 2018, Managing Director & Head-Research Division at Canaccord Adams Ltd. in 2009, CFO & Director-Corporate Development at Shield Therapeutics Plc from 2017 to 2018, Senior Independent Non-Executive Director at Nuformix Plc from 2020 to 2021, Biotechnology Analyst at UBS AG, Global Sector Head-Life Sciences Research at Canaccord Genuity Group, Inc., Chief Corporate Development Officer at Vectura Group Ltd. from 2014 to 2016, Chief Financial Officer at e-Therapeutics Plc in 2021, Chief Financial Officer at Minster Pharmaceuticals Plc in 2010, CFO & Member-Management Board at Pharming Group NV from 2010 to 2012, Biotechnology Analyst at Dresdner Kleinwort Benson Equity, and Biotechnology Analyst at Banc of America Specialist, Inc. Education includes undergraduate degree from University College Dublin in 1988, graduate and doctorate degrees from the University of Cambridge, and a graduate degree from London Business School.
Postes actifs de Karl Keegan
| Sociétés | Poste | Début |
|---|---|---|
Novai Ltd.
 Novai Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Singer Capital Markets Securities Ltd.
 Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/02/2022 |
Anciens postes connus de Karl Keegan
| Sociétés | Poste | Fin |
|---|---|---|
| E-THERAPEUTICS PLC | Directeur Financier/CFO | 31/12/2021 |
| NUFORMIX PLC | Directeur/Membre du Conseil | 24/05/2021 |
| CONROY GOLD AND NATURAL RESOURCES PLC | Directeur/Membre du Conseil | 07/12/2018 |
| SHIELD THERAPEUTICS PLC | Directeur Financier/CFO | 01/08/2018 |
| VECTURA GROUP | Corporate Officer/Principal | 01/07/2016 |
Formation de Karl Keegan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance Provides financial advice and wealth management services | Finance |
Canaccord Genuity Group, Inc.
 Canaccord Genuity Group, Inc. Investment Banks/BrokersFinance Provides investment banking and brokerage services | Finance |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
e-Therapeutics Plc
 e-Therapeutics Plc BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Conroy Gold & Natural Resources Plc
 Conroy Gold & Natural Resources Plc Precious MetalsNon-Energy Minerals Explores and develops gold mining projects | Non-Energy Minerals |
Minster Pharmaceuticals Plc
 Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Adams Ltd.
 Canaccord Adams Ltd. Investment Banks/BrokersFinance Provides corporate finance, investment advice and brokerage services | Finance |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Dresdner Kleinwort Benson Equity | |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banc of America Specialist, Inc.
 Banc of America Specialist, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Singer Capital Markets Securities Ltd.
Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Shield Therapeutics Plc
 Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
Hox Therapeutics Ltd.
 Hox Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for cancer diseases based on the role of HOX genes | Health Technology |
Novai Ltd.
Novai Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
